Effect of improved diagnosis of renal cell carcinoma on the course of the disease
β Scribed by Oded Kessler; Eliahu Mukamel; Gabriel Gillon; Ciro Servadio; Herzlia Hadar; Miriam Konechezky
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 288 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
The impact of the improved diagnosis of renal cell carcinoma (RCC) on the course of the disease was evaluated in 188 patients who were diagnosed and treated at a single medical center. Sixty-seven patients (group A) who had undergone nephrectomy between 1979 and 1983 for RCC initially diagnosed by intravenous pyelography (IVP) were compared with 121 patients (group B) who had undergone nephrectomy between 1983 and 1989, diagnosed by ultrasound and/or computed tomography (CT) scan. Incidental asymptomatic tumors were found in 18 of 67 (26.9%) group A patients and in 57 of 121 (47.1%) group B patients (P < 0,001). The incidence of small tumors of <5 cm in diameter was significantly lower in group A compared to group β¬3 (25.4% vs. 47.9%, respectively, P < 0.01).
The disease-free 5-year survival rate for group A was 40% compared to 80% for group B. It is concluded that the introduction of modern imaging techniques has improved the survival of patients with RCC and decreased the progression rate of the disease.' 0 1994 Wiley-Liss, Inc.
π SIMILAR VOLUMES
## Abstract We have previously reported that connexin (Cx) 32 gene, a member of gap junctions, was specifically downregulated in human renal cell carcinoma (RCC) and it acts as a tumor suppressor against RCC. Because there is no standard therapy for advanced RCC, we investigated the antiβmetastatic
## Abstract ## BACKGROUND The objective of this study was to document the natural history of second lung carcinomas, common second tumors that arise in survivors of Hodgkin disease (HD). ## METHODS The data bases of the Memorial SloanβKettering Cancer Center were searched to retrieve those patie
## RESULTS. The relative uptake of G250 in NU-12 tumors was very high at low protein doses (125% injected dose/g [%ID/g]), but decreased at higher doses, suggesting
## BACKGROUND. The grading of renal cell carcinoma (RCC) has a long history. Currently, there are several grading systems in use throughout the world. There is no consensus regarding which grading system is optimal. ## METHODS. A review of the patient outcome cutpoints of several RCC grading sy